日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Unidirectional recruitment between MeCP2 and KSHV-encoded LANA revealed by CRISPR/Cas9 recruitment assay.

CRISPR/Cas9 募集实验揭示了 MeCP2 与 KSHV 编码的 LANA 之间的单向募集

期刊:PLoS Pathogens
影响因子:4.9
doi:10.1371/journal.ppat.1012972
Lavi Ido, Bhattacharya Supriya, Awase Ankita, Orgil Ola, Avital Nir, Journo Guy, Gurevich Vyacheslav, Shamay Meir
其它
发表日期：2025
文献求助 收藏

Genomic Study of High-Risk Clones of Enterobacter hormaechei Collected from Tertiary Hospitals in the United Arab Emirates

对从阿联酋三级医院收集的高危霍氏肠杆菌克隆株进行基因组研究

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics13070592
Ghazawi, Akela; Anes, Febin; Mouftah, Shaimaa; Elbediwi, Mohammed; Baig, Awase; Alketbi, Muna; Almazrouei, Fatema; Alhashmi, Mariam; Alzarooni, Norah; Manzoor, Ashrat; Habib, Ihab; Strepis, Nikolaos; Nabi, Anju; Khan, Mushtaq
发表日期：2024
文献求助 收藏

Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy

验证一种用于评估非小细胞肺癌患者接受铂类和培美曲塞双药化疗后不良事件的新型因果关系评估量表

期刊:Therapeutic Advances in Drug Safety
影响因子:3.4
doi:10.1177/2042098621991280
Sharma, Jyoti Bhagatram; Krishnamurthy, Manjunath Nookala; Awase, Ankita; Joshi, Amit; Patil, Vijay; Noronha, Vanita; Prabhash, Kumar; Gota, Vikram
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Randomized, Parallel Group, Open-Label Bioequivalence Trial of Intramuscular Pegaspargase in Patients With Relapsed Acute Lymphoblastic Leukemia

复发性急性淋巴细胞白血病患者肌内注射培门冬酶的随机、平行组、开放标签生物等效性试验

期刊:JCO Global Oncology
影响因子:3.2
doi:10.1200/GO.20.00113
Manjunath Nookala Krishnamurthy, Gaurav Narula, Khushboo Gandhi, Ankita Awase, Ruta Pandit, Sunil Raut, Ritu Singh, Vikram Gota, Shripad Dinanath Banavali
免疫
细胞生物学
白血病
肿瘤细胞
发表日期：2020
文献求助 收藏